COVID-19 vaccinated people made in China are not counted as vaccinated: Singapore

The Singapore Health Organization said individuals vaccinated with the COVID-19 vaccine made in China are not considered vaccinated.

“The number of vaccinations in the country reflects only those vaccinated under the national vaccination program,” the Ministry of Health said on Tuesday. “Currently, this includes only those vaccinated with the Moderna COVID-19 and Pfizer-BioNTech / Comirnaty vaccines.”

COVID-19 is a disease caused by the CCP (Chinese Communist Party) virus, also known as coronavirus.

City-state health officials have stated that efficacy data for the Sinovac COVID-19 vaccine, a delta strain, are inadequate. This variant is the most prevalent COVID-19 strain in the country.

“We don’t really have any medical or scientific basis, or we don’t have the data right now to establish how effective Sinovac is for Delta’s infections and serious illnesses.” Health Minister Ong Ye Kung Told reporters on Wednesday.

Singapore began allowing private clinics to manage Sinovac’s CoronaVac in mid-June. World Health Organization (WHO) has approved emergency use from July 1st. As of July 3, approximately 17,000 people have received a single dose.

Evidence from other countries indicates that people taking coronabac are still infected and pose a significant risk, said Kenneth Mack, director of health services in Singapore.

Also, Singapore is different from people vaccinated in national programs, where people vaccinated with CoronaVac are tested for COVID-19 before attending a particular event or entering some venues. It states that it is necessary to receive.

Authorities said people who received Sinovac injections abroad were eligible for a full Pfizer or Moderna vaccine in Singapore. Mack told reporters Wednesday that the government could not guarantee the safety of the combination vaccine.

“There is still a lack of data considering the effectiveness of this strategy with two different vaccines, but we haven’t stopped them. We call this a heterologous vaccination strategy,” Mak said. Said.. “If anyone is eligible to be vaccinated from a national vaccination program, we will allow them to register, but advise on the fact that no evidence is available on the extent of response to other vaccinations. . Previous vaccine. “

In April, Gao Fu, head of the Centers for Disease Control and Prevention (CDC), admitted that some Chinese vaccine products were “not very well protected,” but later his comment was “misunderstanding.” Said. Gao said he commented in the context that Chinese companies should pursue mRNA technology. It was reported that CoronaVac’s protective effect on the CCP virus was only 50.38%.

The Epoch Times has contacted the Ministry of Health for additional comments.

Reuters contributed to this report.

Posted on